OMA1 and myocardial infarction: As detailed in Section 5 and Section 8, pharmacologic inhibition of DRP1 and OMA1, as well as upregulation of autophagy, have been shown in an as-yet limited number of studies to evoke cardioprotection and reduce myocardial infarct size.